Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond ...

Patients with ankylosing spondylitis are associated with an increased risk of developing neurodegenerative diseases, ...

Ankylosing spondylitis primarily affects the joints ... People with severe AS who have not received treatment may be so bent over that they have trouble even lifting their head.

Ankylosing spondylitis, also called Bechterew’s ... about once every 3 months or so to check on your condition and treatment plan. If AS is causing a lot of pain or discomfort, you’ll need ...

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and polyarticular course juvenile idiopathic arthritis. In a phase II, ...

Objective: This study aimed to evaluate the health-related quality of life (HRQoL) in ankylosing spondylitis (AS) patients in the Chaoshan region and identify factors influencing the ASAS Health Index ...

Objectives To examine the impact (if any) of gender on the clinical, functional and patient-reported outcomes of treatment using data pooled from four controlled clinical trials. Methods Study data ...

Introduction Ankylosing spondylitis (AS) is a universal chronic inflammatory rheumatic disease which predominantly results in chronic back pain and stiffness. However, some patients suffering from AS ...

Ankylosing spondylitis (AS) is an immune-mediated rheumatic disorder primarily affecting ... Accordingly, clinical use of IL-17 and TNF inhibitors have shown therapeutic benefits in AS patients and ...